Safety and Efficacy of Omaveloxolone in Friedreich Ataxia ( MOXIe Study)-Reference-Cited by-同舟云学术

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia ( MOXIe Study)

Published:2020-11-05 Issue:2 Volume:89 Page:212-225
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Lynch David R.¹^ORCID,Chin Melanie P.²,Delatycki Martin B.³,Subramony S. H.⁴^ORCID,Corti Manuela⁵,Hoyle J. Chad⁶,Boesch Sylvia⁷,Nachbauer Wolfgang⁷,Mariotti Caterina⁸,Mathews Katherine D.⁹,Giunti Paola¹⁰,Wilmot George¹¹,Zesiewicz Theresa¹²,Perlman Susan¹³,Goldsberry Angie²,O'Grady Megan²,Meyer Colin J.²

Affiliation:

1. Division of Neurology Children's Hospital of Philadelphia Philadelphia PA USA

2. Reata Pharmaceuticals Dallas TX USA

3. Victorian Clinical Genetics Services, Murdoch Children's Research Institute Parkville Victoria Australia

4. Department of Neurology McKnight Brain Institute, University of Florida Health System Gainesville FL USA

5. Department of Pediatrics University of Florida Health System Gainesville FL USA

6. Department of Neurology Ohio State University College of Medicine Columbus OH USA

7. Department of Neurology Medical University Innsbruck Innsbruck Austria

8. Istituto di Ricovero e Cura a Carattere Scientifico–Carlo Besta Neurological Institute Milan Italy

9. Department of Neurology University of Iowa Carver College of Medicine Iowa City IA USA

10. University College London Hospital London United Kingdom

11. Department of Neurology Emory University School of Medicine Atlanta GA USA

12. Department of Neurology University of South Florida Ataxia Research Center Tampa FL USA

13. Department of Neurology University of California, Los Angeles Los Angeles CA USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25934

Reference32 articles.

1. Friedreich Ataxia

2. Friedreich Ataxia

3. Compound heterozygousFXNmutations and clinical outcome in friedreich ataxia

4. Friedreich ataxia- pathogenesis and implications for therapies

5. Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets;Antimicrobial Agents and Chemotherapy;2024-02-06

2. Emerging antioxidant therapies in Friedreich’s ataxia;Frontiers in Pharmacology;2024-02-06

3. At-home Wearable-based Monitoring and Machine Learning Predicts Clinical Measures and Biological Biomarkers of Disease Severity in Friedreich's Ataxia;2024-02-05

4. Transcriptomic profiling of the response to excess iodide in Keap1 hypomorphic mice reveals new gene-environment interactions in thyroid homeostasis;Redox Biology;2024-02

5. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation;American Journal of Physiology-Cell Physiology;2024-02-01